abstract |
A method for producing an antibody suitable for use in a canine. It also provides a caninised antibody that specifically binds to the nerve growth factor (NGF) and neutralizes the ability of canine NGF to bind to the p75 or TrkA NGF receptor. The present invention extends to nucleic acid encoding it and methods for treating dog pain and arthritis using the antibody and / or nucleic acid. |